Propofol is used as an intravenous anesthetic and has come into wider use with the global coronavirus pandemic, as patients often require prolonged periods of mechanical ventilation and treatment of related complications that require the use of this product. Due to the surge in the use of propofol, it is currently on the FDA’s drug shortage list.
In this Application Note we look at how Microfluidizer® Technology plays a vital role in safely producing this widely used drug.
.webp "Microfluidics-Logo-With-TM"){kind=logo}
